This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419–427
Chapman JA, DiSaia PJ, Osann K, Roth PD, Gillotte DL, Berman ML (1996) Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 175: 1195–1200
Di Saia PJ, Brewster WR (2000) Hormone replacement therapy in breast cancer survivors. Am J Obstet Gynecol 183: 517
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy The Women's Health Initiative Randomized Controlled Trial JAMA, April 14, 2004-Vol 291, No. 14
Grady D, Herrington D, Bittner V et al., HERS Research Group (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288: 49–57
Guidozzi F, Daponte A (1999) Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial. Cancer 86: 1013–1018
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605–613
Hunt K, Vessey M, McPherson K (1990) Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 97(12):1080–6
Kutza J, Smith E, Levy B, Jian J, Haugen T, Turek L (2000) Use of hormone replacement therapy (Hrt) And detection of human papillomavirus (Hpv) Dna in postmenopausal women. Ann Epidemiol 10(7): 465–466
Persson I, Yuen J, Bergkvist L, Schairer C (1996) Cancer incidence and mortality in woman receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort. Int J Cancer 29; 67(3): 327–32
Writing Group for the Women's Health Initiative Investigators (2002) Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial. JAMA, Jul 2002; 288: 321–333
Vassilopoulou-Selin R, Asmar L, Hortobagyi GN et al. (1999) Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively. J Clin Oncol 5: 1482–1487
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Weiss, J. (2005). Hormontherapie nach gynäkologischen Malignomen. In: Friedrich, M., Felberbaum, R., Tauchert, S., Diedrich, K. (eds) Manual Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26780-8_23
Download citation
DOI: https://doi.org/10.1007/3-540-26780-8_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22900-1
Online ISBN: 978-3-540-26780-5
eBook Packages: Medicine (German Language)